HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME

This adverse event was reported 70 times

HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PRAZOSIN HYDROCHLORIDE 2 0.0014
1 GLUTATHIONE 1 0.0006
2 BRIGATINIB 1 0.0003
3 LOTEPREDNOL ETABONATE 1 0.0002
4 TAMOXIFEN CITRATE 1 0.0002
5 RAMUCIRUMAB 1 0.0002
6 EDOXABAN TOSYLATE 1 0.0001
7 MECLIZINE HCL 12.5 MG 2 0.0001
8 SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE 1 0.0001
9 VISMODEGIB 1 0.0001
See all drugs enriched for association with HEREDITARY NON-POLYPOSIS COLORECTAL CANCER SYNDROME